Pharmacodynamics of Telavancin (TD-6424), a Novel Bactericidal Agent, against Gram-Positive Bacteria

Telavancin (TD-6424) is a novel lipoglycopeptide that produces rapid and concentration-dependent killing of clinically relevant gram-positive organisms in vitro. The present studies evaluated the in vivo pharmacodynamics of telavancin in the mouse neutropenic thigh (MNT) and mouse subcutaneous infec...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Hegde, Sharath S., Reyes, Noe, Wiens, Tania, Vanasse, Nicole, Skinner, Robert, McCullough, Julia, Kaniga, Koné, Pace, John, Thomas, Roger, Shaw, Jeng-Pyng, Obedencio, Glen, Judice, J. Kevin
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2004
Sujets:
Experimental Therapeutics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC478526/
https://ncbi.nlm.nih.gov/pubmed/15273119
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.48.8.3043-3050.2004
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires